January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
Substantial Drop in HIV Testing among Key Groups during First Year of COVID-19, New CDC Data Reveals
New data showed a sharp drop in HIV tests administered in health care and non-health care settings from 2019 to 2020—primarily among persons disproportionately affected by HIV.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 22, 2022
Merck & Co 21-valent Pneumococcal Conjugate Vaccine Ready for Phase III
The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 17, 2022
FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 16, 2022
Monkeypox: ACP Urges Primary Care to Understand the Threat, Prepare to Address the Risk
The American College of Physicians released guidance on how health care practitioners should deal with possible infections.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 15, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 9, 2022
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for Persons Aged 18 Years and Older
If EUA is granted, the Novavax COVID-19 vaccine would be the first protein-based COVID-19 vaccine available in the US.
CDC Elevates Monkeypox Alert to Level 2, Encourages "Enhanced Precautions"
The CDC raised its monkeypox alert to a level 2 on June 6, reporting more than 1000 cases worldwide and 25 infections confirmed in 12 US states and DC.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 2, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 1, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 31, 2022
CDC: Up to 1 in 5 Adult Survivors Experience Post-COVID Conditions
Compared to persons without evidence of prior infection, survivors are significantly more likely to experience conditions often attributable to post-COVID.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.